Eris Lifesciences shares Q2 FY27 earnings call transcript

Investor Communications View source PDF Explain this filing

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹1166.60

prior close

₹1163.00

announcement price

After-mkt

timing

Nifty Microcap 250market-2.5%+1.4% vs market

Pharmaceuticals peers, median of 173sector-0.8%-0.3% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.2

15m

+0.3

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-2.5+1.4-0.8-0.3

Next day

-0.9-1.1+0.2-0.7-0.2

+0.8-0.8+1.7-0.5+1.3

+4.6+1.3+3.2+0.3+4.3

+5.8+2.5+3.3+1.3+4.5

+6.0pendingpending+1.3+4.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Eris Lifesciences informed the exchanges that the transcript of its analyst and investor call, held after announcing results for the quarter and half year ended September 30, 2026, is available on its investor relations website.

Likely market impact

The filing only provides access to the transcript and contains no new financial guidance or operating figures to assess.